LGND   $116.78  4.68% Market Closed After Close 116.55 -0.20%

Ligand Pharmaceuticals Inc
Total Cash 226.93M
totalCashPerShare 12.422
EBITDA 43.06M
Total Debt 7.64M
quickRatio 14.307
currentRatio 16.82
Total Revenue 133.48M
debtToEquity 0.986
Revenue/Share 7.561
ROA 0.00614
ROE 0.058530003
grossProfits
freeCashflow -18.11M
operatingCashflow 47.76M
earningsGrowth
revenueGrowth 0.575
grossMargins 0.75027
ebitdaMargins 0.32259
operatingMargins 0.17796
profitMargins 0.31573
enterpriseValue 1.81B
forwardPE 18.415731
floatShares 17.89M
sharesOutstanding 18.27M
sharesShort 1.00M
sharesShortPriorMonth 977.37K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.99%
Short Ratio help_outline 10.80%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 42.822
Price To Book help_outline 2.68
earningsQuarterlyGrowth
netIncomeToCommon 42.14M
trailingEps 2.33%
forwardEps 6.23%
enterpriseToEbitda 42.06
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.35 3Q 2024
institutionsCount 345
lastUpdated Nov. 6, 2024, 8:22 p.m.